Crosstalk between Complement and Toll-Like Receptors

Toxicologic Pathology

Volumn 40, Issue 2, 2012, Pages 174-182

  Song, Wen Chao ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

complement; cytokines; inflammation; innate immunity; TLR

Indexed keywords

ANAPHYLATOXIN; CD59 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C5A; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; MEMBRANE COFACTOR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; ZYMOSAN;

ARTICLE; AUTOIMMUNE DISEASE; BIOSYNTHESIS; COMPLEMENT SYSTEM; DEFENSE MECHANISM; ENZYME ACTIVATION; HUMAN; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SEPSIS; TH17 CELL;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; HUMANS; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

ANIMALIA; MUS;

EID: 84858762160     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311428478     Document Type: Article

References (85)

1. Agarwal S. Ferreira V. P. Cortes C. Pangburn M. K. Rice P. A. Ram S. (2010). An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. J Immunol 185, 507–16.
2. Akira S. Takeda K. (2004). Toll-like receptor signalling. Nat Rev Immunol 4, 499–511.
3. Akira S. Takeda K. Kaisho T. (2001). Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2, 675–80.
4. Akira S. Uematsu S. Takeuchi O. (2006). Pathogen recognition and innate immunity. Cell 124, 783–801.
5. Alexopoulou L. Holt A. C. Medzhitov R. Flavell R. A. (2001). Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732–38.
6. Barton G. M. Medzhitov R. (2002). Control of adaptive immune responses by Toll-like receptors. Curr Opin Immunol 14, 380–83.
7. Bettelli E. Carrier Y. Gao W. Korn T. Strom T. B. Oukka M. Weiner H. L. Kuchroo V. K. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–38.
8. Bettelli E. Oukka M. Kuchroo V. K. (2007). T(H)-17 cells in the circle of immunity and autoimmunity. Nature Immunol 8, 345–50.
9. Bjornson A. B. Bjornson H. S. (1977). Activation of complement by opportunist pathogens and chemotypes of Salmonella minnesota. Infect Immun 16, 748–53.
10. Botto M. Dell'Agnola C. Bygrave A. E. Thompson E. M. Cook H. T. Petry F. Loos M. Pandolfi P. P. Walport M. J. (1998). Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19, 56–9.
11. Byrd-Leifer C. A. Block E. F. Takeda K. Akira S. Ding A. (2001). The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol. Eur J Immunol 31, 2448–457.
12. Carroll M. C. (2000). The role of complement in B cell activation and tolerance. Adv Immunol 74, 61–88.
13. Carroll M. C. (2004). A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol 4, 825–31.
14. Chen Z. Koralov S. B. Kelsoe G. (2000). Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med 192, 1339–352.
15. Dunkelberger J. R. Song W. C. (2010a). Complement and its role in innate and adaptive immune responses. Cell Res 20, 34–50.
16. Dunkelberger J. R. Song W. C. (2010b). Role and mechanism of action of complement in regulating T cell immunity. Mol Immunol 47, 2176–186.
17. El-Samalouti V. T. Schletter J. Brade H. Brade L. Kusumoto S. Rietschel E. T. Flad H. D. Ulmer A. J. (1997). Detection of lipopolysaccharide (LPS)-binding membrane proteins by immuno-coprecipitation with LPS and anti-LPS antibodies. Eur J Biochem 250, 418–24.
18. El-Samalouti V. T. Schletter J. Chyla I. Lentschat A. Mamat U. Brade L. Flad H. D. Ulmer A. J. Hamann L. (1999). Identification of the 80-kDa LPS-binding protein (LMP80) as decay-accelerating factor (DAF, CD55). FEMS Immunol Med Microbiol 23, 259–69.
19. Fang C. Zhang X. Miwa T. Song W. C. (2009). Complement promotes the development of inflammatory Th17 cells through synergistic interaction with TLR signaling and IL-6 production. Blood 114(5):1005–015.
20. Fearon D. T. Carroll M. C. (2000). Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 18, 393–422.
21. Ferreira V. P. Cortes C. Pangburn M. K. (2010). Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement. Immunobiol 215, 932–40.
22. Fremeaux-Bacchi V. Moulton E. A. Kavanagh D. Dragon-Durey M. A. Blouin J. Caudy A. Arzouk N. Cleper R. Francois M. Guest G. Pourrat J. Seligman R. Fridman W. H. Loirat C. Atkinson J. P. (2006). Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 17, 2017–025.
23. Hacker H. Vabulas R. M. Takeuchi O. Hoshino K. Akira S. Wagner H. (2000). Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Exp Med 192, 595–600.
24. Hawlisch H. Belkaid Y. Baelder R. Hildeman D. Gerard C. Kohl J. (2005) C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity 22, 415–26.
25. Hayashi F. Smith K. D. Ozinsky A. Hawn T. R. Yi E. C. Goodlett D. R. Eng J. K. Akira S. Underhill D. M. Aderem A. (2001). The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099–103.
26. Haziot A. Ferrero E. Kontgen F. Hijiya N. Yamamoto S. Silver J. Stewart C. L. Goyert S. M. (1996). Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4, 407–14.
27. Heine H. Ulmer A. J. El-Samalouti V. T. Lentschat A. Hamann L. (2001). Decay-accelerating factor (DAF/CD55) is a functional active element of the LPS receptor complex. J Endotoxin Res 7, 227–31.
28. Hemmi H. Kaisho T. Takeuchi O. Sato S. Sanjo H. Hoshino K. Horiuchi T. Tomizawa H. Takeda K. Akira S. (2002). Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3, 196–200.
29. Hemmi H. Takeuchi O. Kawai T. Kaisho T. Sato S. Sanjo H. Matsumoto M. Hoshino K. Wagner H. Takeda K. Akira S. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–45.
30. Hoffmann J. A. (2003). The immune response of Drosophila. Nature 426, 33–8.
31. Holers V. M. (2005). Complement receptors and the shaping of the natural antibody repertoire. Springer Semin Immunopathol 26, 405–23.
32. Hoshino K. Takeuchi O. Kawai T. Sanjo H. Ogawa T. Takeda Y. Takeda K. Akira S. (1999). Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 162, 3749–752.
33. Hourcade D. E. (2006). The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem 281, 2128–132.
34. Iwasaki A. Medzhitov R. (2004). Toll-like receptor control of the adaptive immune responses. Nat Immunol 5, 987–95.
35. Kaczorowski D. J. Afrazi A. Scott M. J. Kwak J. H. Gill R. Edmonds R. D. Liu Y. Fan J. Billiar T. R. (2010). Pivotal advance: The pattern recognition receptor ligands lipopolysaccharide and polyinosine-polycytidylic acid stimulate factor B synthesis by the macrophage through distinct but overlapping mechanisms. J Leukoc Biol 88, 609–18.
36. Kaisho T. Takeuchi O. Kawai T. Hoshino K. Akira S. (2001). Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol 166, 5688–694.
37. Kavanagh D. Richards A. Atkinson J. (2008). Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med 59, 293–309.
38. Kawai T. Akira S. (2006). TLR signaling. Cell Death Differ 13, 816–25.
39. Kawai T. Takeuchi O. Fujita T. Inoue J. Muhlradt P. F. Sato S. Hoshino K. Akira S. (2001). Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167, 5887–894.
40. Kawasaki K. Akashi S. Shimazu R. Yoshida T. Miyake K. Nishijima M. (2000). Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem 275, 2251–254.
41. Kawasaki K. Gomi K. Nishijima M. (2001). Cutting edge: Gln22 of mouse MD-2 is essential for species-specific lipopolysaccharide mimetic action of taxol. J Immunol 166, 11–4.
42. Kemper C. Atkinson J. P. Hourcade D. E. (2010). Properdin: Emerging roles of a pattern-recognition molecule. Annu Rev Immunol 28, 131–55.
43. Kim D. D. Song W. C. (2006). Membrane complement regulatory proteins. Clin Immunol 118, 127–36.
44. Kimura Y. Miwa T. Zhou L. Song W. C. (2008). Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 111, 732–40.
45. Korn T. Bettelli E. Gao W. Awasthi A. Jager A. Strom T. B. Oukka M. Kuchroo V. K. (2007). IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448, 484–87.
46. Le Quintrec M. Roumenina L. Noris M. Fremeaux-Bacchi V. (2010). Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes. Semin Thromb Hemost 36, 641–52.
47. Lemaitre B. Nicolas E. Michaut L. Reichhart J. M. Hoffmann J. A. (1996). The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973–83.
48. Medzhitov R. (2001). Toll-like receptors and innate immunity. Nat Rev Immunol 1, 135–45.
49. Medzhitov R. Preston-Hurlburt P. Janeway C. A., Jr (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394–97.
50. Miwa T. Maldonado M. A. Zhou L. Sun X. Luo H. Y. Cai D. Werth V. P. Madaio M. P. Eisenberg R. A. Song W. C. (2002). Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Am J Pathol 161, 1077–086.
51. Miwa T. Maldonado M. A. Zhou L. Yamada K. Gilkeson G. S. Eisenberg R. A. Song W. C. (2007). Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms. Am J Pathol 170, 1258–266.
52. Modlin R. L. (2002). Mammalian toll-like receptors. Ann Allergy Asthma Immunol 88, 543–47; quiz 548–50, 83.
53. Morrison D. C. Kline L. F. (1977). Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol 118, 362–68.
54. Nurieva R. Yang X. O. Martinez G. Zhang Y. Panopoulos A. D. Ma L. Schluns K. Tian Q. Watowich S. S. Jetten A. M. Dong C. (2007). Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480–83.
55. Ohashi K. Burkart V. Flohe S. Kolb H. (2000). Cutting edge: Heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J Immunol 164, 558–61.
56. Okazaki N. Hazeki K. Izumi T. Nigorikawa K. Hazeki O. (2011). C5a controls TLR-induced IL-10 and IL-12 production independent of phosphoinositide 3-kinase. J Biochem 149, 265–74.
57. Parker C. J. (1996). Molecular basis of paroxysmal nocturnal hemoglobinuria. Stem Cells 14, 396–411.
58. Pasare C. Medzhitov R. (2003a). Toll-like receptors: Balancing host resistance with immune tolerance. Curr Opin Immunol 15, 677–82.
59. Pasare C. Medzhitov R. (2003b). Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033–036.
60. Pasare C. Medzhitov R. (2004). Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21, 733–41.
61. Pasare C. Medzhitov R. (2005). Toll-like receptors: Linking innate and adaptive immunity. Adv Exp Med Biol 560, 11–8.
62. Paul E. Pozdnyakova O. O. Mitchell E. Carroll M. C. (2002). Anti-DNA autoreactivity in C4-deficient mice. Eur J Immunol 32, 2672–679.
63. Pickering M. C. Cook H. T. Warren J. Bygrave A. E. Moss J. Walport M. J. Botto M. (2002). Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31, 424–48.
64. Poltorak A. He X. Smirnova I. Liu M. Y. Van Huffel C. Du X. Birdwell D. Alejos E. Silva M. Galanos C. Freudenberg M. Ricciardi-Castagnoli P. Layton B. Beutler B. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282, 2085–088.
65. Prinz M. Garbe F. Schmidt H. Mildner A. Gutcher I. Wolter K. Piesche M. Schroers R. Weiss E. Kirschning C. J. Rochford C. D. Bruck W. Becher B. (2006). Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest 116, 456–64.
66. Raby A. C. Holst B. Davies J. Colmont C. Laumonnier Y. Coles B. Shah S. Hall J. Topley N. Kohl J. Morgan B. P. Labeta M. O. (2011). Toll-like receptor activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2. Eur J Immunol Jun 1. doi: 10.1002/eji.201041350. [Epub ahead of print ]
67. Rock F. L. Hardiman G. Timans J. C. Kastelein R. A. Bazan J. F. (1998). A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 95, 588–93.
68. Schnare M. Holt A. C. Takeda K. Akira S. Medzhitov R. (2000). Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88. Curr Biol 10, 1139–142.
69. Schwandner R. Dziarski R. Wesche H. Rothe M. Kirschning C. J. (1999). Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem 274, 17406–7409.
70. Sogabe H. Nangaku M. Ishibashi Y. Wada T. Fujita T. Sun X. Miwa T. Madaio M. P. Song W. C. (2001). Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis. J Immunol 167, 2791–797.
71. Spitzer D. Mitchell L. M. Atkinson J. P. Hourcade D. E. (2007). Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J Immunol 179, 2600–608.
72. Steinman L. (2007). A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nature Med 13, 139–45.
73. Takeda K. Kaisho T. Akira S. (2003). Toll-like receptors. Annu Rev Immunol 21, 335–76.
74. Takeuchi O. Akira S. (2001). Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol 1, 625–35.
75. Takeda K. Akira S. (2005). Toll-like receptors in innate immunity. Int Immunol 17, 1–14.
76. Takeuchi O. Hoshino K. Kawai T. Sanjo H. Takada H. Ogawa T. Takeda K. Akira S. (1999). Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11, 443–51.
77. Underhill D. M. Ozinsky A. Hajjar A. M. Stevens A. Wilson C. B. Bassetti M. Aderem A. (1999). The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401, 811–15.
78. Veldhoen M. Hocking R. J. Atkins C. J. Locksley R. M. Stockinger B. (2006). TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179–89.
79. Volman T. J. Hendriks T. Goris R. J. (2005). Zymosan-induced generalized inflammation: Experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 23, 291–97.
80. Walport M. J. (2001a). Complement. First of two parts. N Engl J Med 344, 1058–066.
81. Walport M. J. (2001b). Complement. Second of two parts. N Engl J Med 344, 1140–144.
82. Wang M. Krauss J. L. Domon H. Hosur K. B. Liang S. Magotti P. Triantafilou M. Triantafilou K. Lambris J. D. Hajishengallis G. (2010). Microbial hijacking of complement-Toll-like receptor crosstalk. Sci Signal 3(109):ra11.
83. Yamada K. Miwa T. Liu J. Nangaku M. Song W. C. (2004). Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 172, 3869–875.
84. Zhang X. Kimura Y. Fang C. Zhou L. Sfyroera G. Lambris J. D. Wetsel R. A. Miwa T. Song W. C. (2007). Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110, 228–36.
85. Zhou L. Ivanov I. I. Spolski R. Min R. Shenderov K. Egawa T. Levy D. E. Leonard W. J. Littman D. R. (2007). IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8, 967–74.